Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bazedoxifene Acetate for Osteoporosis in Postmenopausal Women
NCT00205777Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2001
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 30
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Bazedoxifene Acetate with Placebo (2 arms). Primary endpoint: Percentage of Participants With New Vertebral Fractures at Month 84. Started Dec 2001; status: completed.
02
Drugs
bazedoxifene
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00205777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00205777.